Heterogeneous Myocyte Enhancer Factor-2 (Mef2) Activation in Myocytes Predicts Focal Scarring in Hypertrophic Cardiomyopathy

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1012826107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Myocyte Enhancer Factor 2 (MEF2)-Binding Site Is Required forGLUT4Gene Expression in Transgenic Mice

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Myocyte Enhancer Factor-2 (MEF2) in Diseases of Central Nervous System: A Mini Review

Exploratory Research and Hypothesis in Medicine
2016English

Role of Hippocampal Myocyte Enhancer Factor 2 (MEF2) in the Neuroplastic and Cognitive Effects of Environmental Stressors

English

Myocyte Enhancer Factor-Related B-Mef2 Is Developmentally Expressed in B Cells and Regulates the Immunoglobulin J Chain Promoter

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

High Expression of Myocyte Enhancer Factor 2C Predicts Poor Prognosis for Adult Acute Myeloid Leukaemia With Normal Karyotype

British Journal of Haematology
Hematology
2020English

High Sensitivity of Late Gadolinium Enhancement for Predicting Microscopic Myocardial Scarring in Biopsied Specimens in Hypertrophic Cardiomyopathy

PLoS ONE
Multidisciplinary
2014English

Hypertrophic Cardiomyopathy in Pregnancy

Journal of the Royal Society of Medicine
Medicine
1983English

Activation of the Myocyte Enhancer Factor-2 Transcription Factor by Calcium/Calmodulin-Dependent Protein Kinase-Stimulated Binding of 14-3-3 to Histone Deacetylase 5

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Recent Advances in Hypertrophic Cardiomyopathy

F1000Prime Reports
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy